Preventing Sudden Death with n-3 (Omega-3) Fatty Acids and Defibrillators

American Journal of Preventive Medicine

Volumn 31, Issue 4, 2006, Pages

  Kottke, Thomas E ^a   Wu, Lambert A ^b   Brekke, Lee N ^c   Brekke, Mark J ^c   White, Roger D ^d,e  

^a REGIONS HOSPITAL   (United States)

^b Stormont Vail HealthCare   (United States)

^c Brekke Associates   (United States)

^d Mayo Clinic   (United States)

^e City of Rochester Early Defibrillation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; DEFIBRILLATOR; FATTY ACID BLOOD LEVEL; HYPOTHESIS; IMPLANTATION; MORTALITY; POPULATION; PROBABILITY; PROPHYLAXIS; SENSITIVITY ANALYSIS; SUDDEN DEATH;

EID: 33748465509     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2006.06.006     Document Type: Article

References (42)

1. State-specific mortality from sudden cardiac death-United States, 1999. MMWR Morb Mortal Wkly Rep 15 51 (2002) 123-126
2. Elveback L.R., Connolly D.C., and Kurland L.T. Coronary heart disease in residents of Rochester, Minnesota. II. Mortality, incidence, and survivorship, 1950-1975. Mayo Clin Proc 56 (1981) 665-672
3. Goraya T.Y., Jacobsen S.J., Kottke T.E., Frye R.L., Weston S.A., and Roger V.L. Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol 157 (2003) 763-770
4. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
5. Connolly S.J., Gent M., Roberts R.S., et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
6. Desai A.S., Fang J.C., Maisel W.H., and Baughman K.L. Implantable defibrillators for the prevention of mortality in patients with non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292 (2004) 2874-2879
7. Greenberg H., Case R.B., Moss A.J., Brown M.W., Carroll E.R., and Andrews M.L. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43 (2004) 1459-1465
8. Kuck K.H., Cappato R., Siebels J., and Ruppel R. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
9. Wever E.F., Hauer R.N., van Capelle F.L., et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 15 91 (1995) 2195-2203
10. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 26 335 (1996) 1933-1940
11. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
12. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
13. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
14. White R.D., Bunch T.J., and Hankins D.G. Evolution of a community-wide early defibrillation programme experience over 13 years using police/fire personnel and paramedics as responders. Resuscitation 65 (2005) 279-283
15. White R.D., Hankins D.G., and Bugliosi T.F. Seven years' experience with early defibrillation by police and paramedics in an emergency medical services system. Resuscitation 39 (1998) 145-151
16. White R.D., Vukov L.F., and Bugliosi T.F. Early defibrillation by police: initial experience with measurement of critical time intervals and patient outcome. Ann Emerg Med 23 (1994) 1009-1013
17. Hallstrom A.P., Ornato J.P., Weisfeldt M., et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 351 (2004) 637-646
18. Weaver W.D., Copass M.K., Hill D.L., Fahrenbruch C., Hallstrom A.P., and Cobb L.A. Cardiac arrest treated with a new automatic external defibrillator by out-of-hospital first responders. Am J Cardiol 57 (1986) 1017-1021
19. Weaver W.D., Hill D., Fahrenbruch C.E., et al. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med 319 (1988) 661-666
20. Mosesso Jr. V.N., Davis E.A., Auble T.E., Paris P.M., and Yealy D.M. Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest. Ann Emerg Med 32 (1998) 200-207
21. Stults K.R., Brown D.D., and Kerber R.E. Efficacy of an automated external defibrillator in the management of out-of-hospital cardiac arrest: validation of the diagnostic algorithm and initial clinical experience in a rural environment. Circulation 73 (1986) 701-709
22. Myerburg R.J., Fenster J., Velez M., et al. Impact of community-wide police car deployment of automated external defibrillators on survival from out-of-hospital cardiac arrest. Circulation 27 106 (2002) 1058-1064
23. Cummins R.O., Eisenberg M.S., Litwin P.E., Graves J.R., Hearne T.R., and Hallstrom A.P. Automatic external defibrillators used by emergency medical technicians. A controlled clinical trial. JAMA 27 257 (1987) 1605-1610
24. Wang C., Chung M., Lichtenstein A., et al. Effects of omega-3 fatty acids on cardiovascular disease (2004), Agency for Healthcare Research and Quality, Rockville MD March (AHRQ publication 04-E009-02).
25. Black PE. Markov chain. National Institute of Standards and Technology. Available at: http://nist.gov/dads/HTML/markovchain.html
26. Brekke M.J., Kottke T.E., Brekke L.N., and Wu L.A. Design and development of a coronary heart disease decision support tool. Int J Technol Assess Health Care 19 (2003) 555-558
27. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 11 346 (2002) 1113-1118
28. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
29. Bunch T.J., White R.D., Gersh B.J., et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 348 (2003) 2626-2633
30. Eisenberg M.S., Horwood B.T., Cummins R.O., Reynolds-Haertle R., and Hearne T.R. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med 19 (1990) 179-186
31. Wu L.A., Kottke T.E., Friedman P.A., Luria D.M., Grill D.E., and Maurer M.J. Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, population: 1989-1999. J Clin Epidemiol 55 (2002) 458-461
32. Anti-Arrhythmics versus Implantable Defibrillators Investigators. A comparison of anti-arrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
33. Hooper L., Thompson R.L., Harrison R.A., et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332 (2006) 752-760
34. National Institutes of Health Office of Dietary Supplements, National Heart, Lung, and Blood Institute. Working group report on future clinical research directions on omega-3 fatty acids and cardiovascular disease. Available at: www.nhlbi.nih.gov/meetings/workshops/omega-3/omega-3-rpt.htm
35. Mosca L., Appel L.J., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 43 (2004) 900-921
36. Cohen J.T., Bellinger D.C., Connor W.E., et al. A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med 29 (2005) 325-334
37. Rischio & Prevenzione. Available at: www.rischioeprevenzione.it/page.asp?idp=-1774902340.
38. Medical Research Council. ASCEND: A Study of Cardiovascular Events iN Diabetes. University of Oxford, Clinical Trial Service Unit. Available at: www.ctsu.ox.ac.uk/ascend/index.htm.
39. U.S. Census Bureau. Available at: http://factfinder.census.gov/servlet/SAFFFacts?_sse=on.
40. Philips Medical Online Store. Available at: http://shop.medical.philips.com/phstore/catalog/details.asp?product=m3860a&select=region.
41. Sanders G.D., Hlatky M.A., and Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353 (2005) 1471-1480
42. Wonder Laboratories. Available at: www.wonderlabs.com/itemleft.php?itemnum=4460.